Craig Reynolds was CEO of Ebb until early 2017 when he transitioned to a Board Director role after the Series B financing. Prior to Ebb, he was Chief Operating Officer and Board Director of Respironics for ten years through its sale to Philips in 2008 for $5 billion. Craig previously served as President and CEO of Healthdyne Technologies, which merged into Respironics in 1998. In addition to Ebb, Craig currently serves on the Board of Directors of Masimo, Inc (NASDAQ: MASI); Vapotherm, Inc; and Zephyr Sleep Technologies.
Share this post